2 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Recurrent GBM: new trials by email Literature Review of Recurrent GBM trials Research Report on Recurrent GBM
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS) - Recurrent GBM | Phase 1 / Phase 2 | Terminated | SonALAsense, Inc. | 8 | 2023-02-06 | 2024-07-26 |
| Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab Radiation: Intra-operative Radiation Therapy - IORT, Bevacizumab - Glioblastoma, Recurrent Glioblastoma | Phase 2 | Terminated | Xoft, Inc. | 12 | 2021-11-02 | 2024-04-26 |
Glioblastoma (2)
Astrocytoma (2) · Glioma (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Neoplasms, Neuroepithelial (2) · Neuroectodermal Tumors (2)
Bevacizumab (1)
SonALAsense, Inc. (1) · Xoft, Inc. (1)
United States (2)
Corina Andresen, MD (1) · Santosh Kesari, MD (1)
R44CA275508 (1)